Results 131 to 140 of about 18,018 (235)
Acute Effects of Ecstasy on Memory Are more Extensive than Chronic Effects
Introduction: Exposure to 3, 4- methylenedioxymethamphetamine (MDMA) could lead to serotonergic system toxicity in the brain. This system is responsible for learning and memory functions.
Mohamad Bakhtiar Hesam Shariati +6 more
doaj
Classic psychedelics and MDMA have a colorful history of recreational use, and both have recently been re-evaluated as tools for the treatment of psychiatric disorders.
Lukas A. Basedow +5 more
doaj +1 more source
Anxiolytic effects of thymoquinone in the rats exposed to MDMA
Ecstasy 3, 4-Methylenedioxymethamphetamine or MDMA is a psychostimulant drug capable of inducing psychiatric disorders in animals and humans. MDMA produces short-term pleasure effects but prompts to neuropsychiatric problems in the long-term, such as ...
Vidya, Bhagat +2 more
core +1 more source
Reply: The consequences of MDMA use are not easily disentangled from other drug use or lifestyle factors. [PDF]
Quednow BB, Coray RC.
europepmc +1 more source
Grief is overwhelming, isolating, and deeply personal. But what if there was a way to approach it with curiosity rather than fear? In MDMA and Grief, G. Scott Graham shares his groundbreaking personal experiment with MDMA as a tool for exploring and integrating grief.
openaire +2 more sources
Multiyear Wastewater Monitoring of High-Risk Substances Surrounding an Annual Electronic Dance Music Festival, Las Vegas, Nevada, USA, 2023-2025: Surveillance Study. [PDF]
Gerrity D +9 more
europepmc +1 more source
Psychedelic-assisted psychotherapy: Emerging paradigm. [PDF]
Shane D, Akhtar S, Hapke E.
europepmc +1 more source
Making a case for using MDMA-assisted psychotherapy for borderline personality disorder and complex PTSD: a descriptive systematic review of the literature. [PDF]
Kasiviswanathan K +6 more
europepmc +1 more source
Unmasking bias and MDMA-assisted therapy
On August 9th the US Food and Drug Administration’s (FDA) rejected 3,4-methylenedioxymethamphetamine assisted therapy (MDMA-AT) as a treatment for post-traumatic stress disorder (PTSD) despite seemingly positive trial results.
Balázs Szigeti
core +1 more source

